Diabetes News and Research

Latest Diabetes News and Research

Hypertensive pregnancies need rigorous follow up

Women who have hypertensive complications during pregnancy are at increased risk for developing chronic kidney disease and end-stage renal disease, shows a study in the Canadian Medical Association Journal.

28 Jan 2013

Paper says hospitals that do treat patients with anemia have better outcomes

Up to one-third of patients undergoing surgery in Ontario have a treatable form of anemia but are not optimally treated for it.

28 Jan 2013

Sanofi Canada announces new option for emergency treatment of anaphylaxis

Sanofi Canada announces a new option for the emergency treatment of anaphylaxis. Allerject is the first and only 'talking' epinephrine auto-injector in Canada.

28 Jan 2013

FDA accepts Genzyme’s LEMTRADA sBLA for review

Genzyme, a Sanofi Company, announced that the U.S. Food and Drug Administration (FDA) has accepted for review the company's supplemental Biologics License Application (sBLA) file seeking approval of LEMTRADA (alemtuzumab) for the treatment of relapsing multiple sclerosis (RMS).

28 Jan 2013

New AngioSculpt catheters from AngioScore can treat peripheral artery disease below the knee

AngioScore, Inc., a developer of novel angioplasty catheters for use in the treatment of cardiovascular disease, today announced the launch of its new 100 mm length AngioSculpt PTA Scoring Balloon Catheters for the treatment of peripheral artery disease (PAD) below the knee (BTK).

28 Jan 2013

FDA approves Takeda’s NESINA, OSENI and KAZANO for treatment of type 2 diabetes

Takeda Pharmaceutical Company Limited and its wholly-owned subsidiary, Takeda Pharmaceuticals U.S.A., Inc. today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved NESINA (alogliptin) and the fixed-dose combination (FDC) therapies OSENI (alogliptin and pioglitazone) and KAZANO (alogliptin and metformin HCl) for the treatment of type 2 diabetes in adults as adjuncts to diet and exercise.

28 Jan 2013

Research roundup: Does higher Rx drug spending lower Medicare costs?; Price transparency doesn't affect radiological decisions

Researchers aimed to find a relationship between geographic variation in Medicare Part D spending and medication-taking behavior among patients with diabetes or heart failure.

28 Jan 2013

Takeda receives FDA approval for Nesina, Kazano and Oseni to treat type 2 diabetes

The U.S. Food and Drug Administration today approved three new related products for use with diet and exercise to improve blood sugar control in adults with type 2 diabetes: Nesina (alogliptin) tablets, Kazano (alogliptin and metformin hydrochloride) tablets, and Oseni (alogliptin and pioglitazone) tablets.

28 Jan 2013

Low income impacts on diabetes incidence in Ontario

Canadian researchers have found that diabetes incidence is inversely related to income in the province of Ontario.

25 Jan 2013

Undetected comorbidities linked to increased mortality in schizophrenia

Patients with schizophrenia have elevated mortality, the leading causes of which appear to be ischemic heart disease and cancer, a Swedish national cohort study shows.

25 Jan 2013

Weekly aspirin may increase AMD risk

People who take aspirin more than once per week may be at increased risk for developing neovascular age-related macular degeneration, a prospective study has found.

25 Jan 2013

New evidence supports thrombolysis in presence of contraindications

A Norwegian study offers further evidence to support the use of intravenous thrombolysis to treat stroke even in patients with contraindications to the drug.

25 Jan 2013

Antibiotic use common at the end of life

More than one-quarter of hospice patients receive antibiotics in their last week of life, despite the absence of documented infection in most cases, US researchers report.

25 Jan 2013

Botox relieves plantar fasciitis pain

Botulinum toxin A may be more effective than steroids for the treatment of plantar fasciitis, research suggests.

25 Jan 2013

Lasting impact of fetal valproate exposure

Fetal exposure to the antiepileptic drug valproate has a dose-dependent negative impact on children’s IQ at age 6 years, shows a study in The Lancet Neurology.

25 Jan 2013

Simple urine test picks up mesalamine non-adherence

A readily available urine test could identify ulcerative colitis patients who are non-adherent to their mesalamine therapy, research shows.

25 Jan 2013

Efficacy of docusate called into question

Docusate does not significantly improve the management of constipation in hospice patients, show the results of a randomized, placebo-controlled trial.

25 Jan 2013

HDL cholesterol key to fighting lymphoma

High-density lipoprotein cholesterol could provide a novel treatment target for patients with lymphoma, US scientists believe.

25 Jan 2013

‘Imperfect’ test for misplaced epidural catheter studied

A reduced dose of lidocaine may have advantages over a standard dose for detecting inadvertent intrathecal catheter placement during epidural anesthesia, but neither is wholly reliable, say researchers.

25 Jan 2013